Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Liabilities (2016 - 2025)

Marimed (MRMD) has disclosed Total Liabilities for 15 consecutive years, with $137.8 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 6.48% to $137.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.8 million through Dec 2025, up 6.48% year-over-year, with the annual reading at $137.8 million for FY2025, 6.48% up from the prior year.
  • Total Liabilities for Q4 2025 was $137.8 million at Marimed, up from $136.6 million in the prior quarter.
  • The five-year high for Total Liabilities was $137.8 million in Q4 2025, with the low at $37.6 million in Q1 2021.
  • Average Total Liabilities over 5 years is $89.4 million, with a median of $89.3 million recorded in 2023.
  • The sharpest move saw Total Liabilities crashed 36.25% in 2021, then soared 87.54% in 2023.
  • Over 5 years, Total Liabilities stood at $49.2 million in 2021, then grew by 16.24% to $57.2 million in 2022, then soared by 87.54% to $107.2 million in 2023, then rose by 20.74% to $129.4 million in 2024, then increased by 6.48% to $137.8 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $137.8 million, $136.6 million, and $131.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.